Table 1 Baseline demographic characteristics according to the disease group.
| Characteristic | RCD I | RCD II Total | Secondary EATL | De novo EATL |
|---|---|---|---|---|
| Total (male:female) | 43 (12:31) | 50 (19:31) | 26 (11:15) | 13 (11:2) |
| Age at Dx CD (SD) (range) in years | 47 (13.5) (21–75) | 57 (6.5) (40–69) | 59 (11.2) (40–69) | 64.3 (4.5) (56–72) |
| Age at Dx RCD/EATL (SD) (range) in years | 49 (14) (23–86) | 59 (9.5) (47–88) | 61.5 (6.5) (52–79) | 64.3 (3.4) (56–72) |
| Follow‐up: mean (range) in months | 72 (24–240) | 44 (8–146) | 10 (3–50) | 12 (3–36) |
| DQ2 Total | 34 (80%) | 46 (92%) | 25 (96%) | 12 (92.3%) |
| Heterozygous | 23 (54%) | 23 (46%) | 7 (27%) | 4 (30.7%) |
| Homozygous | 11 (26%) | 23 (46%) | 18 (69%) | 8 (61.5%) |
| Aberrant T cells at Dx of RCD and/or EATL: mean % (SD) | 3.0 (1.9) | 60 (25.9) | 68 (24.4) | 9 (13) |
2‐CDA = cladribine; CD, coeliac disease; Dx, diagnosis; EATL, enteropathy‐associated T‐cell lymphoma; RCD, refractory coeliac disease; SD, standard deviation.